PROJECT 002? SIGNAL TRANSDUCTION AND CHEMICAL BIOLOGY RESEARCH PROGRAM PROJECT SUMMARY/ABSTRACT The Signal Transduction and Chemical Biology Research Program (ST) pursues fundamental cancer research to understand patient- and cancer-specific rewiring of signaling networks and the cell cycle, and how stem/progenitor cell plasticity and heterogeneity contribute to tumorigenesis. This information is used to identify new targets that could be the focus of future drug discovery efforts. Accordingly, an overarching goal of ST is to develop novel and/or test small molecule leads against important drivers of cancer initiation and progression and aid the optimization of `leads' to drugs so that ST discoveries can be translated to the clinic as new cancer interventions. The major role of ST leadership is to ensure communication between clinical investigators, population-based researchers and basic scientists to ensure that potentially translatable findings are explored. ST leadership and Vanderbilt-Ingram Cancer Center (VICC) sponsor meetings and retreats to ensure that communication of the basic science discoveries is robust. Program goals will be accomplished by: 1) performing cutting-edge research in single cell biology, stem cells and signaling networks, to identify key targets that confer selective dependencies in human cancers; 2) promoting cutting edge research in chemical biology and development of new cancer therapeutics; and 3) stimulating interactions among the Program membership to accelerate discovery, mentor junior faculty, foster collaborations with clinical programs, promote technologies such as scRNA-seq, super-resolution microscopy, mass cytometry and PROTACS, and work closely with VICC Shared Resources to develop new instrumentation for cancer discovery. There are 44 program members from 13 departments and four schools with $11M in total peer-reviewed funding and NCI making up 39% ($4.3M). Out of 372 publications, 15% are intra-programmatic and 34% are inter-programmatic. Members also have 115 collaborative publications with investigators at other NCI-designated cancer centers.

Public Health Relevance

PROJECT 002 ? SIGNAL TRANSDUCTION AND CHEMICAL BIOLOGY RESEARCH PROGRAM PROJECT NARRATIVE Per the PAR-17-095 FOA, the project narrative is not applicable for the Signal Transduction and Chemical Biology Research Program.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA068485-25
Application #
10024645
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1998-09-01
Project End
2025-08-31
Budget Start
2020-09-01
Budget End
2021-08-31
Support Year
25
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
079917897
City
Nashville
State
TN
Country
United States
Zip Code
37232
Dahlman, Kimberly Brown; Weinger, Matthew B; Lomis, Kimberly D et al. (2018) Integrating Foundational Sciences in a Clinical Context in the Post-Clerkship Curriculum. Med Sci Educ 28:145-154
Covington, Brett C; Spraggins, Jeffrey M; Ynigez-Gutierrez, Audrey E et al. (2018) Response of Hypogean Actinobacterial Genera Secondary Metabolism to Chemical and Biological Stimuli. Appl Environ Microbiol :
Hong, Jun; Maacha, Selma; Belkhiri, Abbes (2018) Transcriptional upregulation of c-MYC by AXL confers epirubicin resistance in esophageal adenocarcinoma. Mol Oncol 12:2191-2208
Bolus, W Reid; Peterson, Kristin R; Hubler, Merla J et al. (2018) Elevating adipose eosinophils in obese mice to physiologically normal levels does not rescue metabolic impairments. Mol Metab 8:86-95
Ramsey, Haley E; Fischer, Melissa A; Lee, Taekyu et al. (2018) A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia. Cancer Discov 8:1566-1581
Wu, Jie; Cai, Hui; Xiang, Yong-Bing et al. (2018) Intra-individual variation of miRNA expression levels in human plasma samples. Biomarkers 23:339-346
Cardin, Dana B; Goff, Laura W; Chan, Emily et al. (2018) Dual Src and EGFR inhibition in combination with gemcitabine in advanced pancreatic cancer: phase I results : A phase I clinical trial. Invest New Drugs 36:442-450
Yang, Jinming; Kumar, Amrendra; Vilgelm, Anna E et al. (2018) Loss of CXCR4 in Myeloid Cells Enhances Antitumor Immunity and Reduces Melanoma Growth through NK Cell and FASL Mechanisms. Cancer Immunol Res 6:1186-1198
Alvarado, Gabriela; Ettayebi, Khalil; Atmar, Robert L et al. (2018) Human Monoclonal Antibodies That Neutralize Pandemic GII.4 Noroviruses. Gastroenterology 155:1898-1907
Sierra, Johanna C; Asim, Mohammad; Verriere, Thomas G et al. (2018) Epidermal growth factor receptor inhibition downregulates Helicobacter pylori-induced epithelial inflammatory responses, DNA damage and gastric carcinogenesis. Gut 67:1247-1260

Showing the most recent 10 out of 2462 publications